 | Up a level |
Jamieson, Catriona, Hasserjian, Robert, Gotlib, Jason, Cortes, Jorge 
ORCID: 0000-0002-8636-1071, Stone, Richard, Talpaz, Moshe ORCID: 0000-0003-3361-3981, Thiele, Juergen, Rodig, Scott and Pozdnyakova, Olga
(2015).
Effect of treatment with a JAK2-selective inhibitor, fedratinib, on bone marrow fibrosis in patients with myelofibrosis.
J. Transl. Med., 13.
LONDON:
BMC.
ISSN 1479-5876
Kvasnicka, Hans Michael ORCID: 0000-0002-3081-1395, Thiele, Juergen, Bueso-Ramos, Carlos E., Sun, William, Cortes, Jorge, Kantarjian, Hagop M. and Verstovsek, Srdan
(2014).
Long-Term Effects of Ruxolitinib on Bone Marrow Morphology in Patients With Myelofibrosis and Comparison to Best Available Therapy.
Clin. Lymphoma Myeloma Leuk., 14.
S. S155 - 1.
DALLAS:
CIG MEDIA GROUP, LP.
ISSN 2152-2669
Kvasnicka, Hans Michael ORCID: 0000-0002-3081-1395, Thiele, Juergen, Bueso-Ramos, Carlos E., Sun, William, Cortes, Jorge, Kantarjian, Hagop M. and Verstovsek, Srdan
(2015).
Long-term bone marrow stromal changes in patients with myelofibrosis treated with ruxolitinib.
Clin. Lymphoma Myeloma Leuk., 15.
S. S234 - 1.
DALLAS:
CIG MEDIA GROUP, LP.
ISSN 2152-2669
Kvasnicka, Hans Michael, Thiele, Juergen, Bueso-Ramos, Carlos E., Sun, William, Cortes, Jorge ORCID: 0000-0002-8636-1071, Kantarjian, Hagop M. and Verstovsek, Srdan
(2018).
Long-term effects of ruxolitinib versus best available therapy on bone marrow fibrosis in patients with myelofibrosis.
J. Hematol. Oncol., 11.
LONDON:
BMC.
ISSN 1756-8722